gray market tirzepatide Wegovy Outperforms in Reducing Major Adverse Cardiovascular Events Weight-Loss Drug Zepbound Faces Supply
Description
The incidence of heart failure was reduced by 59%, non-fatal stroke by 27%, and non-fatal heart attack by 47%
*Obesity GLP-1 Ozempic and Mounjaro Source: IQVIA Analysis
Remember, informed decisions lead to better outcomes
GLP-1 surge, oncology stars to power industrys earnings growth over the next 18 months: Moodys, Fierce Pharma, March 15, 2024
The exact number of treatments needed to achieve optimal results will vary from patient to patient
